Previous Article | Next Article 
Infection and Immunity, September 2001, p. 5264-5269, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5264-5269.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
CD4+ T Helper 1 Cells Facilitate Regression of
Murine Lyme Carditis
Linda K.
Bockenstedt,1,*
Insoo
Kang,1
Christopher
Chang,1,
David
Persing,2,
Adrian
Hayday,3,4,§ and
Stephen W.
Barthold5
Department of Internal Medicine,1
and Section of Immunobiology,3 Yale
University School of Medicine, and Department of Biology,
Yale University,4 New Haven, Connecticut 06520;
Department of Laboratory Medicine, Mayo Clinic, Rochester,
Minnesota 559052; and Center for
Comparative Medicine, Schools of Medicine and Veterinary Medicine,
University of California, Davis, California 956165
Received 12 February 2001/Returned for modification 10 April
2001/Accepted 21 May 2001
 |
ABSTRACT |
Murine Lyme borreliosis, caused by infection with the spirochete
Borrelia burgdorferi, results in acute arthritis
and carditis that regress as a result of B. burgdorferi-specific immune responses. B. burgdorferi-specific antibodies can attenuate arthritis
in mice deficient in both B cells and T cells but have no effect on
carditis. Because macrophages comprise the principal immune cell in
carditis, T-cell responses that augment cell-mediated immunity may
be important for carditis regression. To investigate this hypothesis,
we examined the course of Lyme carditis in mice selectively deficient
in B cells or 
T cells. Our results show that carditis regresses
in B-cell-deficient B10.Ak mice but not in 
T-cell-deficient mice, independently of the mouse strain background.
Despite prominent macrophage infiltrates, hearts from B. burgdorferi-infected 
T-cell-deficient mice had less mRNA
for tumor necrosis factor alpha as measured by reverse transcription-PCR compared to infected control mice. Anti-inflammatory cytokine mRNA levels were equivalent. Adoptive transfer of gamma interferon-secreting CD4+ T cells into infected 
T-cell-deficient mice promoted carditis resolution. These results show
that 
T cells can promote resolution of murine Lyme carditis and
are the first demonstration of a beneficial role for CD4+ T
helper 1 cells in this disease.
 |
INTRODUCTION |
Lyme borreliosis, due to infection
with the spirochete Borrelia burgdorferi, has a variety of
clinical manifestations, including arthritis and carditis
(12). In murine Lyme borreliosis, these disease
manifestations follow a predictable time course, with the most severe
inflammatory responses detectable within the first 2 to 4 weeks of
infection (9). Thereafter, acute inflammation in joints
and hearts regresses even though animals remain persistently infected.
Acquired immunity is necessary for disease regression, as shown by the
persistence of acute inflammation in both joints and the hearts of
infected severe combined immunodeficiency (SCID) mice, which lack T and
B cells (10, 32).
B. burgdorferi-specific antibodies are critical for
protective immunity and for arthritis modulation (8, 23).
Passive immunization of mice with serum from B. burgdorferi-infected mice (immune serum) can prevent experimental
infection (5), and administration of immune serum to
infected SCID mice causes regression of arthritis (8).
However, immune serum does not ameliorate carditis, which remains
active in SCID mice. Carditis differs from arthritis in that >90% of
the inflammatory infiltrate is comprised of macrophages (4,
30). Adaptive immune responses that promote macrophage
activation rather than B-cell effector functions alone may be
particularly important for resolving Lyme carditis in mice.
The dominance of B. burgdorferi-specific T helper 1 (Th1)
cell responses in disease-susceptible mouse strains (19,
22) and in humans with chronic Lyme arthritis (21,
36) has led to the prevailing notion that T-cell responses that
promote cell-mediated immunity are detrimental to the host. Several
studies evaluating murine Lyme arthritis challenge this supposition.
Pretreatment of mice with monoclonal antibody (MAb) to interleukin-12
(IL-12), a cytokine favoring Th1 cell development, increases the
pathogen burden (1), and the absence of the Th1 cell
cytokine gamma interferon (IFN-
) enhances joint swelling
(13). Some disease-resistant mouse strains also exhibit a
Th1 cytokine profile after B. burgdorferi infection
(17). We have shown that reduction in Th2 responses in a
resistant mouse strain does not necessarily enhance arthritis severity
(33). Moreover, fewer spirochetes can be detected in joints of mice deficient in the anti-inflammatory Th2 cell cytokine IL-10 (14), suggesting that in normal hosts, inflammation
may be suppressed at the expense of the spirochete burden. Taken
together, these findings suggest that Th1 cell effector functions could have a positive impact on the outcome of B. burgdorferi
infection, but no study to date has directly shown this.
Lyme carditis, a macrophage-mediated pathology not directly influenced
by B. burgdorferi-specific antibodies, is an especially suitable model for assessing the contribution of Th1 cells to disease
regression. In this study, we examined the course of Lyme carditis in
mice genetically deficient in B cells and those selectively deficient
in 
T cells. This experimental design allowed us to assess the
impact of T-cell immune responses other than those affecting B-cell
function, as well as the requirement for 
T cells, the dominant
T-cell population, in carditis regression. Our results confirm that
immune serum does not reduce carditis and show that Th1 cells can
promote resolution rather than exacerbation of this disease manifestation.
 |
MATERIALS AND METHODS |
Spirochetes.
An infectious pathogenic clone of B. burgdorferi strain N40 (cN40) was used in all experiments
(6). Frozen aliquots of low-passage cN40 were thawed and
grown to log phase in modified Barbour-Stoenner-Kelly (BSK II) medium
at 33°C prior to each experiment (3). Spirochetes were
visualized to assess viability and counted by dark-field microscopy
using a Petroff-Hausser chamber before inoculation into mice.
Mice.
B-cell-deficient,
B10.Ak-Igh-6tm1Cgn (µMT) mice were kindly
provided by Charles Janeway (Yale University School of Medicine); these mice lack mature B cells due to targeted disruption of the
immunoglobulin (Ig) µ heavy-chain gene (20). Age- and
sex-matched inbred control B10.A/SGSNJ (B10.Ak) mice were
purchased from the Jackson Laboratories (Bar Harbor, Maine). Mice
expressing the T-cell receptor (TCR) 
/
mutation on
three genetic backgrounds, varying in their susceptibility to Lyme
borreliosis, were used: (BALB/c × 129)F1 TCR

/
intercrossed to homozygosity for the TCR

/
mutation and heterozygote littermate controls
(27), the N6 intercross of (BALB/c × 129)F1 TCR 
/
mice backcrossed six times
with disease-susceptible C3H/HeN (C3H) mice, and
B6.129S2-TCR
tm1Mom (B6 TCR 
/
) and B6
control mice, purchased from the Jackson Laboratories. Mice were housed
in filter frame cages and screened by antibody and PCR to ensure
absence of specific pathogens, including mouse hepatitis virus and
parvovirus. Except where noted otherwise, all mice were infected at 4 to 5 weeks of age by intradermal inoculation with the indicated dose of
cN40 in 100 µl of BSK II medium and sacrificed by carbon dioxide inhalation.
Passive immunization.
Immune mouse serum (IMS) was derived
from B10.Ak mice inoculated 30 days previously with
104 cN40. Infection among serum donor mice was confirmed by
culture prior to pooling of the sera.
B10.Ak-Igh-6tm1Cgn and B10.Ak
age-matched mice were passively immunized by subcutaneous injection of
500 µl of a 1:10 dilution of IMS or normal mouse serum (NMS) at days
12, 16, 20, and 23 of infection and then sacrificed for analysis on
infection day 28.
Bb-specific IgG ELISA.
Immunoglobulin G (IgG) responses to
cN40 lysates were analyzed in serial dilutions of serum specimens from
infected mice by standard enzyme-linked immunosorbent assay (ELISA)
techniques as previously described (33). Results are
reported for a 1:20,000 dilution.
T-cell cytokine analysis.
T cells from infected mice were
isolated from pooled lymph node (LN) cells by negative selection using
rat anti-CD19 and anti-CD11b MAb, (Pharmingen, San Diego, Calif.) and
Biomag goat anti-rat IgG and goat anti-mouse IgM magnetic beads
(PerSeptive Biosystems, Framingham, Mass.), as specified by the
manufacturer. Purified T cells were then separated into
CD4+ and CD8+ populations by negative selection
using rat anti-CD8 or rat anti-CD4 MAb (Pharmingen), respectively, and
goat anti-rat IgG magnetic beads. The purity of each T-cell
subpopulation was >95%, as assessed by flow cytometry. A total of 5 × 106 purified CD4+ and CD8+ T
cells were stimulated in triplicate for 72 h with 50 µg of B. burgdorferi sonicate per ml and irradiated
splenocytes from uninfected mice as described elsewhere
(33). Harvested supernatants were assayed for IFN-
and
IL-4 by a sandwich ELISA as specified by the manufacturer (Pharmingen).
Concentrations of cytokines were calculated based on standard curves
obtained from serial dilutions of recombinant IFN-
and IL-4
(Biosource, Camarillo, Calif.) (33).
T-cell adoptive transfer.
CD4+ and
CD8+ T-cell subsets were purified by negative selection
from the spleens and LNs of B6 mice 14 and 31 days after infection. Then 5 × 106 purified CD4+ or
CD8+T cells were injected intravenously into the tail vein
of TCR 
/
mice after the establishment of carditis at
infection days 14 and 31. At the end of the experimental period, the
presence of the transferred population was confirmed by flow cytometry
of the splenocytes, and the cytokine production of T cells was assessed as described above.
Histopathology.
Hearts and hindlimb joints (knee and
tibiotarsal joints) were immersion fixed in neutral buffered formalin
(pH 7.2), demineralized (joints only), and then processed and stained
with hematoxylin-eosin by routine histologic techniques
(10). Tibiotarsal joints were scored for arthritis
severity on a scale of 0 (negative) to 3 (severe), as described
elsewhere (7). Carditis (active or chronic) was evaluated
in sagittal sections through the heart, which included the aortic valve
(2).
RT-PCR of mRNA and densitometry.
mRNA was extracted from
heart tissue homogenized in Tri-Reagent (Molecular Research Center,
Inc., Cincinnati, Ohio) using the Tri-Reagent RNA isolation kit
according to the manufacturer's recommendations. cDNA was synthesized
by reverse transcription-PCR (RT-PCR) using random primers (Stratagene,
La Jolla, Calif.) in a 50-µl total volume as previously described
(25). Tenfold dilutions of cDNA (corresponding to 1, 0.1, and 0.01 µl of the 50-µl reaction volume) were amplified by PCR
using oligonucleotide primers for tumor necrosis factor alpha
(TNF-
), IFN-
, transforming growth factor
(TGF-
), IL-4,
IL-10, or
2 tubulin at a final concentration of 20 µM
each in the presence of 10 mM deoxynucleoside triphosphates. PCR was
carried out for 35 cycles, with initial template denaturation at 94°C
for 45 s, annealing at 60°C for 45 s, and extension at 72°C for 1.5 min. Amplification was completed by a final incubation at 72°C for 10 min. Primer pairs for IFN-
(405 bp) and IL-10 (177 bp) were purchased from Stratagene and Biosource (Camarillo, Calif.),
respectively. The primer sequences and predicted amplified product
sizes for the remaining cytokines were as follows: 5'-TNF-
, 5'-ATGAGCACAGAAAGCATGATC; 3'-TNF-
,
3'-TACAGGCTTGTCACTCGAATT (276 bp); 5'-TGF-
,
5'-CGGGGCGACCTGGGCACCATCCATGAC; 3'-TGF-
,
3'-CTGCTCCACCTTGGGCTTGCGACCCAC (404 bp); 5'-IL-4,
5'-ACGGAGATGGATGTGCCAAACGTC; 3'-IL-4,
3'-GCATCATGCAAATGGATTACTCGT (279 bp); 5'-
2
tubulin, 5'-GGCGCCCTCTGTGTAGTGGCCTTTGGCCCA; and 3'-
2 tubulin, 3'-CAGGCTGGTCAATGTGGCAACCAGATCGGT
(300 bp). We analyzed 25 µl of a 100-µl reaction volume by
2% agarose gel electrophoresis for visualization of the expected
product (Gibco Laboratories, Grand Island, N.Y.). Images were scanned
and quantified by densitometry using Bio-Rad Multi-Analyst software.
Bands were outlined by boxes of constant size; a background of one
pixel depth outside the perimeter of the sample box was subtracted from
the quantified scan (data not shown).
Quantitative B. burgdorferi detection by
competitive PCR.
DNA was extracted from preweighed mouse ear
samples using a modified Qiamp tissue kit protocol (Qiagen, Chatsworth,
Calif.), and spirochete DNA was amplified using a 256-bp region of the B. burgdorferi flagellin gene as described earlier
(18). Reaction mixtures contained 100 copies of a 356-bp
competitive internal control consisting of a 303-bp segment of
Staphylococcus aureus plasmid, pub112, flanked by the
B. burgdorferi primer sequences found in the target. In
addition, digoxigenin-11-dUTP was used in all reaction mixtures so
that amplified products could be quantitated using the PCR ELISA
detection kit (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) as
described previously (18).
 |
RESULTS |
B cells are not required for resolution of Lyme carditis in
B10.Ak mice.
B. burgdorferi-infected
SCID mice develop arthritis and carditis that persist through at least
60 days of infection. Passive transfer of IMS into infected SCID mice
resolves arthritis but not carditis, suggesting that antibody alone is
insufficient for carditis resolution. In fact, carditis regresses in
infected B10.Ak-Igh-6tm1Cgn mice, which possess
immature B cells but are unable to make antibodies (Table
1, panel A). The enhanced arthritis
observed in infected B10.Ak-Igh-6tm1Cgn mice
was attenuated with passive transfer of IMS (Table 1, panel B,
P < 0.05 [Fisher exact test]). However, IMS had no
apparent effect on the course of carditis, which remained active at 28 days of infection, even when the infecting spirochete dose was reduced
10-fold from 104 (panel A) to 103 (panel B) and
the spirochete burden in ear tissues had been reduced to a level
comparable to that of the controls.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Attenuation of arthritis, but not carditis, by passive
transfer of immune mouse serum into B. burgdorferi- infected
B10.Ak-Igh-6tm1Cgn micea
|
|

T cells are required for resolution of carditis in
B. burgdorferi-infected mice.
Carditis regression
in B-cell-deficient but not SCID mice, which lack both B and T cells,
strongly suggests a role for T cells in this process. We therefore
examined the evolution of carditis in B. burgdorferi-infected TCR 
/
mice, which lack

T cells due to targeted disruption of the TCR
chain. These
mice were chosen over mice deficient in all T cells (TCR


/
mice) because they permit assessment of the
effects of 
T cells when potentially regulatory 
T cells
are still present (35). All B. burgdorferi-infected mice developed carditis within 14 days of
infection (Table 2), but this disease
manifestation remained active only in 
T-cell-deficient mice,
independent of genetic background (Table 2 and Fig. 1A). In contrast,
all control mice resolved inflammation by day 45 (Table 2 and Fig.
1B). Although B. burgdorferi-specific IgG titers were lower in TCR

/
mice compared to control mice, there was no
difference in arthritis severity between the TCR 
/
and control mice at 14 days of infection and equal regression of
arthritis by 45 days (data not shown).

View larger version (123K):
[in this window]
[in a new window]
|
FIG. 1.
Hematoxylin-eosin stain of representative heart tissues.
(A) Heart base of a B6 TCR  / mouse at 45 days of
infection. Note margination of leukocytes along the endothelial
surface above the aortic valve, and infiltration of leukocytes in
the wall and adventitia of the root of the aorta (upper left and
insert) and ventricular myocardium (lower left). (A) Heart base of
a B6 mouse at 45 days of infection. There is no inflammation remaining
near the aortic valve (valve leaflet in center and insert) or root of
the aorta (upper left). Magnification, ×175.
|
|
Cytokine production by B. burgdorferi-infected TCR

/
mice.
Previous studies have shown that T
cells from either C3H or B6 mice produce IFN-
but not IL-4 after
B. burgdorferi infection (17, 22).
Purified CD4+ and CD8+ LN T-cell subsets
isolated from control C3H mice infected for 14 or 45 days produced
IFN-
(Fig. 2), a result consistent
with the known Th1 dominance of this strain (19, 22).
While T cells from B6 mice produced less IFN-
, the pattern of
cytokine expression at 14 and 45 days of infection was identical to
that of C3H mice (Fig. 2), with no IL-4 detected in culture
supernatants of T cells from either mouse strain.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 2.
CD4+ and CD8+ T cells from
B. burgdorferi-infected mice produce IFN- after in
vitro restimulation. CD4+ and CD8+ T cells were
purified by negative selection from regional lymph nodes from infected
C3H or B6 mice at the indicated day of infection. Bars represent the
mean units of IFN- present per milliliter of supernatant of pooled
CD4+ or CD8+ T cells stimulated with
B. burgdorferi sonicate as determined by ELISA ± the standard error of the mean. Results are representative of three
experiments.
|
|
We also analyzed mRNA from 14-day-infected heart tissues to determine
whether there were substantial differences in the levels
of
proinflammatory and anti-inflammatory cytokines in the absence
of


T cells (Fig.
3). mRNAs for
TNF-

, IFN-

, TGF-

, and IL-10
were present in both infected TCR

/
and infected control TCR
+/
hearts (Fig.
3). When analyzed by densitometry and adjusted for
tubulin
amplification, less TNF-

was present in TCR

/
hearts compared to controls (most notable at the 1:10 dilution
of cDNA
template). The increase in TGF-

in TCR

/
hearts
suggested visually in Fig.
3 was not substantiated by
densitometry.
IL-4 mRNA could not be detected in any of the experimental
groups.

View larger version (79K):
[in this window]
[in a new window]
|
FIG. 3.
Cytokine production in B. burgdorferi-infected C3H hearts in the absence of  T cells.
mRNA was extracted from 14-day-infected C3H TCR  /
and TCR +/ hearts and cDNAs generated by RT as
described in Materials and Methods. Serial tenfold dilutions of the
cDNA products were amplified by PCR and sized by agarose gel
electrophoresis. Tubulin amplification was performed in parallel for
each cytokine examined. These results are representative of three
separate analyses of C3H or B6 hearts and show a relative reduction in
TNF- in TCR  / hearts compared to controls
(confirmed by band densitometry; data not shown).
|
|
IFN-
-producing CD4+ T cells facilitate carditis resolution
in B. burgdorferi-infected TCR 
/
mice.
Adoptive transfer experiments were performed to determine
the effect of T cells on established carditis in B. burgdorferi-infected B6 TCR 
/
mice (Table
3). Infected TCR 
/
mice received either CD4+ or CD8+ T-cell
subsets isolated from wild-type mice infected for a similar duration,
commencing on day 14 of infection. These T-cell subsets produced
IFN-
but not IL-4 after in vitro restimulation prior to transfer and
when reanalyzed from LN cells retrieved from recipient mice at
infection day 41 (Table 3). No exacerbation of arthritis or carditis
was noted when T-cell-deficient mice were reconstituted with T-cell
subsets. Moreover, recipients of IFN-
secreting CD4+ T
cells had a statistically significant reduction in the prevalence of
carditis, with the majority of mice resolving inflammation by the end
of the experimental period (Table 3, P = 0.009, Fisher exact test).
 |
DISCUSSION |
The dominance of CD4+ Th1 cells in mouse strains
susceptible to B. burgdorferi-induced disease and
in humans with Lyme arthritis has led to the notion that Th1 cell
effector functions impair host control of the pathogen and
promote disease (22, 34). Our present study evaluated the
role of T cells in resolution of Lyme carditis and provides evidence
that CD4+ Th1 cells may have a beneficial effect on this
disease manifestation. B. burgdorferi-infected mice
deficient in 
T cells and unable to resolve carditis in
comparison to similarly infected immunocompetent mice do resolve this
disease manifestation when reconstituted with infection-primed
IFN-
-secreting CD4+ T cells. Although B. burgdorferi-specific antibody is also enhanced in CD4+
T-cell-reconstituted TCR 
/
mice, T cell effects on
antibody production alone are unlikely to account for these findings.
Immune serum does not resolve carditis in SCID, B-cell-deficient, or

T-cell-deficient mice (7, 8, 23). Our results in
B10.Ak B-cell-deficient mice confirm these observations and
show also that although immune serum can reduce arthritis severity and
the number of spirochetes in ear tissues within 2 weeks of
administration, carditis regression is not accelerated.
Previous studies in SCID mice (10, 31) and major
histocompatibility complex MHC class II-deficient mice lacking
CD4+ T cells show that T cells are not required for the
development of Lyme carditis, which is composed largely of macrophages
(29). However, cardiac infiltrates in immunocompetent mice
contain small numbers of CD4+ and CD8+ T cells
(29), which likely modulate the activity of macrophages responding to spirochetes. mRNAs for proinflammatory cytokines (IL-1
, TNF-
, and IFN-
) derived from both macrophages and T cells have been demonstrated in heart tissues within the first week of
infection and persist for at least 42 days (15). We found
that mRNA for T-cell-associated cytokines was also present in TCR

/
mice, which possess other cell populations,
including natural killer cells and 
cells that may produce
cytokines in this setting. We were unable to detect the Th2-cell
cytokine IL-4 by either cytokine ELISA of restimulated draining LN
cells or by RT-PCR of heart tissue mRNA. Moreover, equivalent levels of
IL-10 mRNA were noted in TCR 
/
and control infected
mouse hearts. This observation is consistent with a recent study
showing that IL-10 and TGF-
mRNA levels in C3H mouse hearts during
peak or resolving carditis are no different than those of uninfected
controls (26). Taken together, these findings suggest that
other non-Th2 associated T-cell effector functions facilitate carditis
resolution. In this regard, the lower level of TNF-
mRNA in infected
TCR 
/
mice was particularly noteworthy and
unexpected given the degree of carditis observed. Because TNF-
production is subject to feedback regulation, one cannot directly
correlate mRNA levels with the observed pathology. However, diminished
expression of mRNA for this cytokine could indicate that macrophages
are not fully activated in the absence of 
T cells. Other cell
populations that produce IFN-
, a cytokine promoting macrophage
activation, appear unable to compensate for 
T-cell deficiency.
Inefficient macrophage clearance of spirochetes or their antigens
within hearts may be one reason carditis remains active through 45 days
in TCR 
/
mice. While the experimental conditions of
our study delineate a beneficial role for Th1 cells on carditis, these
conditions do preclude a role for local production of antibody, which
through opsonization of antigens may have an impact on carditis
evolution in immunologically intact hosts. Indeed, any immune parameter that assists macrophage function may help eliminate spirochete products
and resolve carditis.
The results of our studies, which demonstrate a beneficial role for
CD4+ T cells in the host immune response to B. burgdorferi infection, contrast with a recent report describing
their potential for causing disease (24). In that study,
B. burgdorferi-infected B6 Rag
/
mice
reconstituted with naive CD4+ T cells developed severe lung
inflammation and myocarditis, two disease manifestations atypical for
murine Lyme borreliosis. Naive CD4+ T cells transferred
into uninfected Rag
/
mice undergo homeostatic
proliferation to fill the available lymphoid compartments, a process
that increases the T-cell pool and allows for the expansion of
self-reactive T cells (11, 16, 28). The differences
between the outcome of T-cell reconstitution in our study using TCR

/
mice and those using Rag
/
mice can
be explained by both homeostatic proliferation of transferred T cells
and by the presentation of foreign antigens to fuel the T-cell
response. TCR 
/
mice possess B cells and produce low
levels of antibodies that control pathogen burden and also modulate
disease through the opsonization and clearance of proinflammatory
lipoprotein antigens. This critical arm of host defense is absent from
Rag
/
mice, which still possess dendritic cells and
macrophages that phagocytose and present Borrelia antigens
to naive T cells. Naive T cells transferred into infected
Rag
/
mice can be readily activated by these
professional antigen-presenting cells. In this study, we attempted to
preserve the natural evolution of B. burgdorferi
infection and host immune response by transferring infection-primed T
cells into TCR 
/
mice with established carditis. In
this setting, IFN-
secreting CD4+ T cells did not
exacerbate disease but instead promoted the complete resolution of
carditis. These results provide the first example of a beneficial role
for Th1 cells on the course of Lyme borreliosis.
 |
ACKNOWLEDGMENTS |
We thank Jialing Mao, Mary Campbell, Debby Beck, and Gordon
Terwilliger for technical assistance and Ruth Montgomery and Joseph Craft for review of the manuscript.
This work was supported by National Institutes of Health grants
AR42637, BAA-94-31, AI 45253, AI26815, AI27855, and AR38932; the G. Harold and Leila Y. Mathers Charitable Foundation; the American Heart
Association; and the Arthritis Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Section of
Rheumatology, Yale University School of Medicine, 333 Cedar St., P.O.
Box 208031, New Haven, CT 06520-8031. Phone: (203) 785-7063. Fax: (203)
785-7053. E-mail: linda.bockenstedt{at}yale.edu.
Present address: Department of Surgery, Duke University Medical
Center, Durham, NC 27705.
Present address: Diagnostics Research, Corixa Corp., Seattle,
WA 98104.
§
Present address: Department of Immunobiology, Medical Schools of
Guy's, King's, and St. Thomas's, University of London, London SE1
9RT, United Kingdom.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Anguita, J.,
D. H. Persing,
M. Rincon,
S. W. Barthold, and E. Fikrig.
1996.
Effect of anti-interleukin 12 treatment on murine Lyme borreliosis.
J. Clin. Investig.
97:1028-1034[Medline].
|
| 2.
|
Armstrong, A. L.,
S. W. Barthold,
D. H. Persing, and D. S. Beck.
1992.
Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi.
Am. J. Trop. Med. Hyg.
47:249-258.
|
| 3.
|
Barbour, A. G.
1984.
Isolation and cultivation of Lyme disease spirochetes.
Yale J. Biol. Med.
57:521-525[Medline].
|
| 4.
|
Barthold, S. W.,
D. S. Beck,
G. M. Hansen,
G. A. Terwilliger, and K. D. Moody.
1990.
Lyme borreliosis in selected strains and ages of laboratory mice.
J. Infect. Dis.
162:133-138[Medline].
|
| 5.
|
Barthold, S. W., and L. K. Bockenstedt.
1993.
Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.
Infect. Immun.
61:4696-4702[Abstract/Free Full Text].
|
| 6.
|
Barthold, S. W.,
M. S. de Souza,
J. L. Janotka,
A. L. Smith, and D. H. Persing.
1993.
Chronic Lyme borreliosis in the laboratory mouse.
Am. J. Pathol.
143:419-420[Abstract].
|
| 7.
|
Barthold, S. W.,
M. deSouza, and S. Feng.
1996.
Serum-mediated resolution of Lyme arthritis in mice.
Lab. Investig.
74:57-67[Medline].
|
| 8.
|
Barthold, S. W.,
S. Feng,
L. K. Bockenstedt,
E. Fikrig, and K. Feen.
1997.
Protective and arthritis-resolving activity in serum of mice infected with Borrelia burgdorferi.
Clin. Infect. Dis.
25(Suppl. 1):S9-S17.
|
| 9.
|
Barthold, S. W.,
D. H. Persing,
A. L. Armstrong, and R. A. Peeples.
1991.
Kinetics of Borrelia burgdorferi dissemination and evolution of disease following intradermal inoculation of mice.
Am. J. Pathol.
139:263-273[Abstract].
|
| 10.
|
Barthold, S. W.,
C. L. Sidman, and A. L. Smith.
1992.
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency.
Am. J. Trop. Med. Hyg.
47:605-613.
|
| 11.
|
Bell, E. B.,
S. M. Sparshott,
M. T. Drayson, and W. L. Ford.
1987.
The stable and permanent expansion of functional T lymphocytes in athymic nude rats after a single injection of mature T cells.
J. Immunol.
139:1379-1384[Abstract].
|
| 12.
|
Bockenstedt, L. K., and S. E. Malawista.
1995.
Lyme disease, p. 1234-1249.
In
R. R. Rich (ed.), Clinical immunology. Mosby-Year Book, St. Louis, Mo.
|
| 13.
|
Brown, C. R., and S. L. Reiner.
1999.
Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon.
Infect. Immun.
67:3329-3333[Abstract/Free Full Text].
|
| 14.
|
Brown, J. P.,
J. F. Zachary,
C. Teuscher,
J. J. Weis, and R. M. Wooten.
1999.
Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense.
Infect. Immun.
67:5142-5150[Abstract/Free Full Text].
|
| 15.
|
Doyle, M. K.,
S. R. Telford III,
L. Criscione,
S. R. Lin,
A. Spielman, and E. M. Gravallese.
1998.
Cytokines in murine Lyme carditis: Th1 cytokine expression follows expression of proinflammatory cytokines in a susceptible mouse strain.
J. Infect. Dis.
177:242-246[Medline].
|
| 16.
|
Ernst, B.,
D.-S. Lee,
J. M. Chang,
J. Sprent, and C. D. Surh.
1999.
The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery.
Immunity
11:173-181[CrossRef][Medline].
|
| 17.
|
Ganapamo, F.,
V. A. Dennis, and M. T. Philipp.
2000.
Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi.
Infect. Immun.
68:7162-7165[Abstract/Free Full Text].
|
| 18.
|
Germer, J.,
B. Ryckmann,
M. Moro,
E. Hofmeister,
S. W. Barthold,
L. Bockenstedt, and D. H. Persing.
1999.
Quantitative detection of Borrelia burgdorferi with a microtiter-based competitive PCR assay.
Mol. Diagnosis.
4:185-193[CrossRef][Medline].
|
| 19.
|
Kang, I.,
S. W. Barthold,
D. H. Persing, and L. K. Bockenstedt.
1997.
T helper cell cytokines in the early evolution of murine Lyme arthritis.
Infect. Immun.
65:3107-3111[Abstract].
|
| 20.
|
Kitamura, D.,
J. Roes,
R. Kuhn, and K. Rajewsky.
1991.
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin µ chain gene.
Nature
350:423-426[CrossRef][Medline].
|
| 21.
|
Lengl-Janssen, B.,
A. F. Strauss,
A. C. Steere, and T. Kamradt.
1994.
The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis.
J. Exp. Med.
180:2069-2078[Abstract/Free Full Text].
|
| 22.
|
Matyniak, J. E., and S. L. Reiner.
1995.
T helper phenotype and genetic susceptibility in experimental Lyme disease.
J. Exp. Med.
181:1251-1254[Abstract/Free Full Text].
|
| 23.
|
McKisic, M. D., and S. W. Barthold.
2000.
T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease.
Infect. Immun.
68:5190-5197[Abstract/Free Full Text].
|
| 24.
|
McKisic, M. D.,
W. L. Redmond, and S. W. Barthold.
2000.
T cell-mediated pathology in murine Lyme borreliosis.
J. Immunol.
165:6096-6099.
|
| 25.
|
Montgomery, R. R.,
S. E. Malawista,
K. J. M. Feen, and L. K. Bockenstedt.
1996.
Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: Exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.
J. Exp. Med.
183:261-270[Abstract/Free Full Text].
|
| 26.
| Montgomery, R. R., X.-M. Wang, and
S. E. Malawista. 2001. Murine Lyme disease: no evidence for
active immune downregulation in resolving or subclinical infection. J. Infect. Dis., in press.
|
| 27.
|
Philpott, K. L.,
J. L. Viney,
G. Kay,
S. Rastan,
E. M. Gardiner,
S. Chae,
A. C. Hayday, and M. J. Owen.
1992.
Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells.
Science
256:1448-1452[Abstract/Free Full Text].
|
| 28.
|
Rocha, B.,
N. Dautigny, and P. Pereira.
1989.
Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/8 ratios in vivo.
Eur. J. Immunol.
19:905-911[Medline].
|
| 29.
|
Ruderman, E. M.,
J. S. Kerr,
S. R. Telford III,
A. Spielman,
L. H. Glimcher, and E. M. Gravallese.
1995.
Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4+ T cell interactions.
J. Infect. Dis.
171:362-370[Medline].
|
| 30.
|
Ruderman, E. M.,
J. S. Kerr,
S. R. Telford III,
A. Spielman,
L. H. Glimcher, and E. M. Gravallese.
1993.
Early murine Lyme carditis is macrophage-mediated and does not require Class II MHC antigen.
Arth. Rheum.
36:S42.
|
| 31.
|
Schaible, U. E.,
M. D. Kramer,
C. Museteanu,
G. Zimmer,
H. Mossman, and M. M. Simon.
1989.
The severe combined immunodeficiency (scid) mouse: a laboratory model for the analysis of Lyme arthritis and carditis.
J. Exp. Med.
170:1427-1432[Abstract/Free Full Text].
|
| 32.
|
Schaible, U. E.,
S. Gay,
C. Museteanu,
M. D. Kramer,
G. Zimmer,
K. Eichmann,
U. Museteanu, and M. M. Simon.
1990.
Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manisfests predominantly in the joints, heart, and liver.
Am. J. Pathol.
137:811-820[Abstract].
|
| 33.
|
Shanafelt, M.-C.,
I. Kang,
S. W. Barthold, and L. K. Bockenstedt.
1998.
Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T cell costimulatory pathway.
Infect. Immun.
66:266-271[Abstract/Free Full Text].
|
| 34.
|
Sigal, L. H.
1997.
Lyme disease: a review of aspects of its immunology and immunopathogenesis.
Annu. Rev. Immunol.
15:63-92[CrossRef][Medline].
|
| 35.
|
Vincent, M. S.,
K. Roessner,
D. Lynch,
D. Wilson,
S. M. Cooper,
J. Tschopp,
L. H. Sigal, and R. C. Budd.
1996.
Apoptosis of Fashigh CD4+ synovial T cells by Borrelia-reactive Fas-ligandhigh  T cells in Lyme arthritis.
J. Exp. Med.
184:2109-17[Abstract/Free Full Text].
|
| 36.
|
Yssel, H.,
M. D. Shanafelt,
C. Sodenberg,
R. Schneider, and G. Peltz.
1991.
Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis.
J. Exp. Med.
174:593-601[Abstract/Free Full Text].
|
Infection and Immunity, September 2001, p. 5264-5269, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5264-5269.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liu, N., Belperron, A. A., Booth, C. J., Bockenstedt, L. K.
(2009). The Caspase 1 Inflammasome Is Not Required for Control of Murine Lyme Borreliosis. Infect. Immun.
77: 3320-3327
[Abstract]
[Full Text]
-
Olson, C. M. Jr., Bates, T. C., Izadi, H., Radolf, J. D., Huber, S. A., Boyson, J. E., Anguita, J.
(2009). Local Production of IFN-{gamma} by Invariant NKT Cells Modulates Acute Lyme Carditis. J. Immunol.
182: 3728-3734
[Abstract]
[Full Text]
-
Tupin, E., Benhnia, M. R.-E.-I., Kinjo, Y., Patsey, R., Lena, C. J., Haller, M. C., Caimano, M. J., Imamura, M., Wong, C.-H., Crotty, S., Radolf, J. D., Sellati, T. J., Kronenberg, M.
(2008). NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA
105: 19863-19868
[Abstract]
[Full Text]
-
Belperron, A. A., Dailey, C. M., Booth, C. J., Bockenstedt, L. K.
(2007). Marginal Zone B-Cell Depletion Impairs Murine Host Defense against Borrelia burgdorferi Infection. Infect. Immun.
75: 3354-3360
[Abstract]
[Full Text]
-
Lunemann, J. D., Gelderblom, H., Sospedra, M., Quandt, J. A., Pinilla, C., Marques, A., Martin, R.
(2007). Cerebrospinal Fluid-Infiltrating CD4+ T Cells Recognize Borrelia burgdorferi Lysine-Enriched Protein Domains and Central Nervous System Autoantigens in Early Lyme Encephalitis. Infect. Immun.
75: 243-251
[Abstract]
[Full Text]
-
Xu, Q., Seemanapalli, S. V., Lomax, L., McShan, K., Li, X., Fikrig, E., Liang, F. T.
(2005). Association of Linear Plasmid 28-1 with an Arthritic Phenotype of Borrelia burgdorferi. Infect. Immun.
73: 7208-7215
[Abstract]
[Full Text]
-
Guerau-de-Arellano, M., Alroy, J., Bullard, D., Huber, B. T.
(2005). Aggravated Lyme Carditis in CD11a-/- and CD11c-/- Mice. Infect. Immun.
73: 7637-7643
[Abstract]
[Full Text]
-
Widhe, M., Skogman, B. H., Jarefors, S., Eknefelt, M., Enestrom, G., Nordwall, M., Ekerfelt, C., Croner, S., Bergstrom, S., Forsberg, P., Ernerudh, J.
(2005). Up-regulation of Borrelia-specific IL-4- and IFN-{gamma}-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis. Int Immunol
17: 1283-1291
[Abstract]
[Full Text]
-
Guerau-de-Arellano, M., Alroy, J., Huber, B. T.
(2005). {beta}2 Integrins Control the Severity of Murine Lyme Carditis. Infect. Immun.
73: 3242-3250
[Abstract]
[Full Text]
-
Liu, N., Montgomery, R. R., Barthold, S. W., Bockenstedt, L. K.
(2004). Myeloid Differentiation Antigen 88 Deficiency Impairs Pathogen Clearance but Does Not Alter Inflammation in Borrelia burgdorferi-Infected Mice. Infect. Immun.
72: 3195-3203
[Abstract]
[Full Text]
-
Salazar, J. C., Pope, C. D., Sellati, T. J., Feder, H. M. Jr, Kiely, T. G., Dardick, K. R., Buckman, R. L., Moore, M. W., Caimano, M. J., Pope, J. G., Krause, P. J., Radolf, J. D.
(2003). Coevolution of Markers of Innate and Adaptive Immunity in Skin and Peripheral Blood of Patients with Erythema Migrans. J. Immunol.
171: 2660-2670
[Abstract]
[Full Text]
-
Bockenstedt, L. K., Shanafelt, M.-C., Belperron, A., Mao, J., Barthold, S. W.
(2003). Humoral Immunity Reflects Altered T Helper Cell Bias in Borrelia burgdorferi-Infected {gamma}{delta} T-Cell-Deficient Mice. Infect. Immun.
71: 2938-2940
[Abstract]
[Full Text]